Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5 - PubMed (original) (raw)
. 2010 Mar 15;184(6):3016-24.
doi: 10.4049/jimmunol.0901277. Epub 2010 Feb 12.
Affiliations
- PMID: 20154207
- DOI: 10.4049/jimmunol.0901277
Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5
Alexandre Dalet et al. J Immunol. 2010.
Abstract
Peptide splicing is a newly described mode of production of antigenic peptides presented by MHC class I molecules, whereby two noncontiguous fragments of the parental protein are joined together after excision of the intervening segment. Three spliced peptides have been described. In two cases, splicing involved the excision of a short intervening segment of 4 or 6 aa and was shown to occur in the proteasome by transpeptidation resulting from the nucleophilic attack of an acyl-enzyme intermediate by the N terminus of the other peptide fragment. For the third peptide, which is derived from fibroblast growth factor-5 (FGF-5), the splicing mechanism remains unknown. In this case, the intervening segment is 40 aa long. This much greater length made the transpeptidation model more difficult to envision. Therefore, we evaluated the role of the proteasome in the splicing of this peptide. We observed that the spliced FGF-5 peptide was produced in vitro after incubation of proteasomes with a 49-aa-long precursor peptide. We evaluated the catalytic mechanism by incubating proteasomes with various precursor peptides. The results confirmed the transpeptidation model of splicing. By transfecting a series of mutant FGF-5 constructs, we observed that reducing the length of the intervening segment increased the production of the spliced peptide, as predicted by the transpeptidation model. Finally, we observed that trans-splicing (i.e., splicing of fragments from two distinct proteins) can occur in the cell, but with a much lower efficacy than splicing of fragments from the same protein.
Similar articles
- [Antigenic peptides for peptide splicing in the proteosome].
Vigneron N. Vigneron N. Bull Mem Acad R Med Belg. 2010;165(5-6):305-9. Bull Mem Acad R Med Belg. 2010. PMID: 21513118 French. - A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming.
Michaux A, Larrieu P, Stroobant V, Fonteneau JF, Jotereau F, Van den Eynde BJ, Moreau-Aubry A, Vigneron N. Michaux A, et al. J Immunol. 2014 Feb 15;192(4):1962-71. doi: 10.4049/jimmunol.1302032. Epub 2014 Jan 22. J Immunol. 2014. PMID: 24453253 - An antigenic peptide produced by peptide splicing in the proteasome.
Vigneron N, Stroobant V, Chapiro J, Ooms A, Degiovanni G, Morel S, van der Bruggen P, Boon T, Van den Eynde BJ. Vigneron N, et al. Science. 2004 Apr 23;304(5670):587-90. doi: 10.1126/science.1095522. Epub 2004 Mar 4. Science. 2004. PMID: 15001714 - Peptide splicing by the proteasome.
Vigneron N, Ferrari V, Stroobant V, Abi Habib J, Van den Eynde BJ. Vigneron N, et al. J Biol Chem. 2017 Dec 22;292(51):21170-21179. doi: 10.1074/jbc.R117.807560. Epub 2017 Nov 6. J Biol Chem. 2017. PMID: 29109146 Free PMC article. Review. - Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity.
Vigneron N, Van den Eynde BJ. Vigneron N, et al. Curr Opin Immunol. 2012 Feb;24(1):84-91. doi: 10.1016/j.coi.2011.12.002. Epub 2011 Dec 27. Curr Opin Immunol. 2012. PMID: 22206698 Review.
Cited by
- Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing.
Soh WT, Roetschke HP, Cormican JA, Teo BF, Chiam NC, Raabe M, Pflanz R, Henneberg F, Becker S, Chari A, Liu H, Urlaub H, Liepe J, Mishto M. Soh WT, et al. Nat Commun. 2024 Feb 7;15(1):1147. doi: 10.1038/s41467-024-45339-3. Nat Commun. 2024. PMID: 38326304 Free PMC article. - Systematic identification of 20S proteasome substrates.
Pepelnjak M, Rogawski R, Arkind G, Leushkin Y, Fainer I, Ben-Nissan G, Picotti P, Sharon M. Pepelnjak M, et al. Mol Syst Biol. 2024 Apr;20(4):403-427. doi: 10.1038/s44320-024-00015-y. Epub 2024 Jan 29. Mol Syst Biol. 2024. PMID: 38287148 Free PMC article. - Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family.
Deshmukh FK, Ben-Nissan G, Olshina MA, Füzesi-Levi MG, Polkinghorn C, Arkind G, Leushkin Y, Fainer I, Fleishman SJ, Tawfik D, Sharon M. Deshmukh FK, et al. Nat Commun. 2023 May 30;14(1):3126. doi: 10.1038/s41467-023-38404-w. Nat Commun. 2023. PMID: 37253751 Free PMC article. - Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example.
Lichti CF, Wan X. Lichti CF, et al. Semin Immunol. 2023 Mar;66:101730. doi: 10.1016/j.smim.2023.101730. Epub 2023 Feb 22. Semin Immunol. 2023. PMID: 36827760 Free PMC article. Review. - InvitroSPI and a large database of proteasome-generated spliced and non-spliced peptides.
Roetschke HP, Rodriguez-Hernandez G, Cormican JA, Yang X, Lynham S, Mishto M, Liepe J. Roetschke HP, et al. Sci Data. 2023 Jan 10;10(1):18. doi: 10.1038/s41597-022-01890-6. Sci Data. 2023. PMID: 36627305 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials